| Serial Number | 97238190 |
| Word Mark | ONSERO |
| Filing Date | Tuesday, January 25, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 27, 2022 |
| Goods and Services | Pharmaceutical products for the treatment of health and mental health conditions, in particular depression, anxiety, mood disorders, post-traumatic stress disorders, compulsive disorders and migraines; pharmaceutical products for the treatment of health and mental health diseases and disorders in particular depression, anxiety, mood disorders, post-traumatic stress disorders, compulsive disorders and migraines; pharmaceutical products for the treatment of neurological and psychiatric diseases and disorders; diagnostic agents, preparations, and substances for medical purposes; none of the foregoing including pharmaceutical products in the fields of multiple sclerosis, HIV/AIDS, reproductive health, namely, fertility, or oncology, metabolic diseases, or endocrinological diseases |
| Goods and Services | Pharmaceutical and biopharmaceutical research and development; drug discovery services; laboratory research services relating to pharmaceuticals and diagnostics, namely, research in the fields of health and mental health diseases and disorders, neurological diseases and disorders, and psychiatric diseases and disorders; provision of information and data relating to medical research and development in the fields of health and mental health diseases and disorders, neurological diseases and disorders, and psychiatric diseases and disorders; consultancy in the field of pharmaceutical and pharmaceutical diagnostics research; none of the foregoing including pharmaceutical products in the fields of multiple sclerosis, HIV/AIDS, reproductive health, namely, fertility, or oncology, metabolic diseases, or endocrinological diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 31, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 31, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Onsero Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02116 |
| Party Name | Onsero Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20004 |
| Event Date | Event Description |
| Monday, March 4, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 4, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Sunday, November 19, 2023 | WITHDRAWAL OF ATTORNEY GRANTED |
| Sunday, November 19, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Friday, November 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, November 17, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, November 17, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, August 1, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, June 21, 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, June 6, 2023 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Monday, June 5, 2023 | ASSIGNED TO PETITION STAFF |
| Monday, May 15, 2023 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Monday, January 16, 2023 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, December 27, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 27, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 7, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, November 19, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 15, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 15, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 15, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, November 3, 2022 | ASSIGNED TO EXAMINER |
| Monday, January 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 28, 2022 | NEW APPLICATION ENTERED |